Therefore, with the growing interest in harnessing the therapeutic effects of stem progenitor cells for neonatal lung injury, it is necessary to perform further thorough investigations to understand the behavior of MSCs from different populations (ie, lung, umbilical cord blood [UCB], bone marrow) in the presence and absence of lung injury, and how this could affect potential cellbased therapies for BPD.